Ticker
MRKRCompany Name
MARKER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -10.88M | -202% | $ 5.39M |
3/31/2025 | $ -12.57M | -220.73% | $ 5.7M |
12/31/2024 | $ -10.91M | -165.53% | $ 6.59M |
9/30/2024 | $ -8.57M | -158.91% | $ 5.4M |
6/30/2024 | $ -10.9M | -292.42% | $ 3.73M |
3/31/2024 | $ -14.39M | -433.29% | $ 3.32M |
12/31/2023 | $ -16.44M | -496.51% | $ 3.31M |
9/30/2023 | $ -20.38M | -224.83% | $ 9.06M |
6/30/2023 | $ -26.9M | -210.86% | $ 12.76M |
3/31/2023 | $ -20.63M | -161.41% | $ 12.78M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for MARKER THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -17.2M ] / Revenues [ $ 679.98K ]
(=) OCF % [ -2529.74% ]
Minimum
Mar 31, 2021
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |